SQI Diagnostics Inc V.SQD.H

Healthcare Medical Devices

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.

TSXV:SQD.H - Post by User

SQI Diagnostics Inc > QDEL earnings

<< Previous

Bullboard Posts

Next >>

Post by SQIReaderon May 04, 2022 5:06pm

160 Views

Post# 34656609

QDEL earnings

revenues increased 167% to over 1Billion$...

rapid immunoassay revenue increased by $655.1 million in the 1st quarter of 2022 to $892.8 million driven primarily by significan sales of quickVue at Home OTC Covid 19 tests, as well as increased sales of Sofia Influenza + Sars and Sofia Influenza tests.

...increasing brand strength and growing installed base of Sofia analyzers continue to propel our market expansion

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"